DK0540582T3 - Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller - Google Patents

Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller

Info

Publication number
DK0540582T3
DK0540582T3 DK91913240.7T DK91913240T DK0540582T3 DK 0540582 T3 DK0540582 T3 DK 0540582T3 DK 91913240 T DK91913240 T DK 91913240T DK 0540582 T3 DK0540582 T3 DK 0540582T3
Authority
DK
Denmark
Prior art keywords
growth hormone
crystals
hormone crystals
preparation
hgh
Prior art date
Application number
DK91913240.7T
Other languages
English (en)
Inventor
Flemming Junker
Claus Friis Theisen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0540582T3 publication Critical patent/DK0540582T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK91913240.7T 1990-07-13 1991-07-12 Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller DK0540582T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (da) 1990-07-13 1990-07-13

Publications (1)

Publication Number Publication Date
DK0540582T3 true DK0540582T3 (da) 1995-01-30

Family

ID=8107212

Family Applications (2)

Application Number Title Priority Date Filing Date
DK168790A DK168790D0 (da) 1990-07-13 1990-07-13
DK91913240.7T DK0540582T3 (da) 1990-07-13 1991-07-12 Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK168790A DK168790D0 (da) 1990-07-13 1990-07-13

Country Status (17)

Country Link
US (1) US6117984A (da)
EP (1) EP0540582B1 (da)
JP (1) JP2524446B2 (da)
AT (1) ATE110745T1 (da)
AU (1) AU666465B2 (da)
BG (1) BG61267B1 (da)
CA (1) CA2086087C (da)
DE (1) DE69103755T2 (da)
DK (2) DK168790D0 (da)
ES (1) ES2060399T3 (da)
HU (2) HU210323B (da)
IE (1) IE67054B1 (da)
NZ (1) NZ238904A (da)
PT (1) PT98297B (da)
RU (1) RU2108341C1 (da)
WO (1) WO1992000998A1 (da)
ZA (1) ZA915446B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894023B1 (en) * 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
DK168790D0 (da) * 1990-07-13 1990-07-13 Novo Nordisk As
ES2185625T3 (es) * 1991-12-20 2003-05-01 Novo Nordisk As Formulacion farmaceutica estabilizada que incluye hormona de crecimiento e histidina.
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
DK0946169T3 (da) * 1996-12-20 2003-04-22 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af et præparat med vedvarende frigivelse
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6451347B1 (en) 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
DE60000622T2 (de) * 1999-06-10 2003-02-27 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Einkapselung von kristallen mit mehrschichtigem überzug
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
MXPA03001092A (es) 2000-08-07 2003-09-25 Nektar Therapeutics Al Corp Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
AU2001294459A1 (en) 2000-10-06 2002-04-15 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
ZA200505305B (en) * 2002-12-31 2007-07-25 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
EP2460530A3 (en) 2002-12-31 2012-08-29 Althea Technologies, Inc. Human growth hormone crystals and methods for preparing them
ZA200505306B (en) * 2002-12-31 2006-09-27 Altus Pharmaceuticals Inc Complexes of protein crystals and ionic polymers
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
EP1976551A4 (en) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF
AU2007333959A1 (en) * 2006-12-18 2008-06-26 Altus Pharmaceuticals Inc. Human growth hormone formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA653324A (en) * 1962-12-04 G. Brink Norman Growth hormone and methods of preparing the same
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2595278A (en) * 1950-04-28 1952-05-06 Armour & Co Preparation of insulin from pancreas glands
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US2897117A (en) * 1955-02-10 1959-07-28 Univ Alberta Insulin process
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
ATE62598T1 (de) * 1984-10-04 1991-05-15 Monsanto Co Verzoegerte freisetzung biologisch aktiver somatotropine.
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
IL85255A0 (en) * 1987-01-30 1988-07-31 Int Minerals & Chem Corp Recovery of somatotropin from dilute aqueous solutions
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
EP0355460B1 (en) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
DK168790D0 (da) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals

Also Published As

Publication number Publication date
DK168790D0 (da) 1990-07-13
DE69103755D1 (de) 1994-10-06
DE69103755T2 (de) 1995-02-23
EP0540582B1 (en) 1994-08-31
AU666465B2 (en) 1996-02-15
NZ238904A (en) 1993-04-28
BG61267B1 (en) 1997-04-30
US6117984A (en) 2000-09-12
IE67054B1 (en) 1996-02-21
RU2108341C1 (ru) 1998-04-10
PT98297A (pt) 1992-05-29
BG97281A (bg) 1994-03-24
ES2060399T3 (es) 1994-11-16
CA2086087C (en) 1999-09-14
ATE110745T1 (de) 1994-09-15
HU9300067D0 (en) 1993-04-28
AU8284691A (en) 1992-02-04
JP2524446B2 (ja) 1996-08-14
WO1992000998A1 (en) 1992-01-23
JPH05507497A (ja) 1993-10-28
HU210323B (en) 1995-03-28
CA2086087A1 (en) 1992-01-14
IE912444A1 (en) 1992-01-15
PT98297B (pt) 1999-01-29
ZA915446B (en) 1992-03-25
EP0540582A1 (en) 1993-05-12
HUT64086A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
DK0540582T3 (da) Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK272389A (da) Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
FI102969B1 (fi) Lämpö- ja pH-stabiileja subtilisiinianalogeja ja menetelmä niiden valmistamiseksi
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
YU45724B (sh) Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata
DK254386D0 (da) Pyridinderivater, fremgangsmaade til fremstilling heraf og praeparaterindeholdende disse forbindelser
DK282985D0 (da) S-(carbamoyl-phenylselenyl)-derivater af glutathion og af aminomercaptocarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
PT84258A (en) Process for the preparation of cross-protective human monoclonal antibodies and of pharmaceutical compositions containing the same
DK126888D0 (da) Bisphosphonsyrederivater og terapeutiske praeparater indeholdende disse forbindelser
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
DK343088D0 (da) Pyrazinderivater, fremgangsmaade til fremstilling heraf, midler indeholdende disse og fremgangsmaader til regulering af plantevaekst
DK415388A (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
IS3862A (is) Aðferð til framleiðslu á amínósýru azetidinyl umbreyttum pyridone afleiðum og notkun þeirra í lækningaskyni
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK245787D0 (da) Nicotinsyrederivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK46187A (da) Plantevaekst-regulerende praeparater og fremgangsmaade til regulering af plantevaekst
IT1211796B (it) Procedimento per l'accrescimento di cristalli
PT84353A (en) Purified human angiogenic factor method for its preparation andpharmaceutical preparations
DK26591D0 (da) Cytidin-5'-diphosphatalkanoler og -glyceroler, fremgangsmaade til fremstilling heraf og praeparater indeholdende disse forbindelser
IT1237515B (it) Procedimento per la preparazione di primicina idrosolubile e suoi componenti e composizioni farmaceutiche che li contengono.
NO149454C (no) Proteinkonsentrat for tilsetning til dyrefor, fremstilling av konsentratet fra gress og andre plantevekster og anvendelse av konsentratet i dyrefor
LV5784B4 (lv) Cilveka audzeju nekrozes faktora monoklonalas antivielas
DK222886D0 (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser